|
Bextra Lawyer Says: Don’t Feel Guilty, Get a Bextra Lawyer
By
Joe Regan
By now you have probably heard about a little drug known as BEXTRA. Just in case you have been out of the loop, it is a medicine that treats the pain and inflammation of arthritis. On April 7, the Food and Drug Administration requested that Pfizer suspend sales of BEXTRA in the United States in light of the FDA's position that there is an increased cardiovascular risk for all prescription non-steroidal anti-inflammatory arthritis medicines, as well as the increased rate of rare, serious skin reactions.
The Bad news.
The bad news is this. If you have been taking Bextra, you have been unknowingly increasing your risk of having cardiovascular complications.
The Good News.
The good news is, not only can you get a refund, in most cases, from your local pharmacy, but you may also have a strong case if you decide to contact a lawyer that specializes in Dangerous Drugs.
If you have taken any kind of dangourous drug, you should never feel guilty about finding out more about your legal options. Research not only the medicine in question, but also alternative medicines so you don’t end up in a similar situation. When you feel comfortable talking about the situation, find a Lawyer specialized in the drug in question. Which in this case would be a Bextra Lawyer.
Until next time, Have a great day!
Contact an Experienced
Bextra Lawyer today.
Find a Bextra
Product
Liability lawyer today at hugesettlements.
For more information on Dangourous drugs, visit our
Dangerous Drugs Lawyer page. Article Source:
http://EzineArticles.com/
Bextra
Valdecoxib is a prescription drug used in the treatment of osteoarthritis,
rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is
classified as a nonsteroidal anti-inflammatory drug, or NSAID, and should not be
taken by anyone allergic to these types of medications.
Valdecoxib was manufactured and marketed under the brand name BextraŽ by G. D.
Searle & Company. It was available by prescription in tablet form until 2005,
when it was removed from the market due to concerns about possible increased
risk of heart attack and stroke.
Side-effects and withdrawal
On April 7, 2005, Pfizer withdrew Bextra from the US market on recommendation by
the FDA, citing an increased risk of heart attack and stroke and also the risk
of a serious, sometimes fatal, skin reaction. This was a result of recent
attention to prescription NSAIDs, such as Merck's Vioxx. Other reported
side-effects were angina and Stevens-Johnson syndrome.
Pfizer first acknowledged cardiovascular risks associated with Bextra in October
of 2004. The American Heart Association soon after was presented with a report
indicating patients using Bextra while recovering from heart surgery were 2.19
times more likely to suffer a stroke or heart attack than those taking placebos.
Personal injury
With the removal of the drug from the market, there is expected to be a surge
in personal injury claims, many in the form of class action, to seek
compensation.
|
